AI is writing more code than humans—and much of it isn’t secure. Corridor’s founders think they’ve found a way to catch the mistakes before attackers do.
Latent Health is tapping into the $200 billion market for specialty drugs with AI agents that help doctors convince insurers to more quickly approve drugs and treatments people need.
In this week’s edition of InnovationRx, we look at Roche’s big AI drug development bet, an E. coli outbreak in raw milk cheddar, R1 Therapeutics’ $78 million raise, and more.
The Christmas Eve agreement—billed as Nvidia’s biggest deal in its three-decade history—landed at a precarious moment for Groq. Now Nvidia is betting on Groq’s inference-speed tech inside a newly announced chip platform.
One of the most popular ways to view the Epstein Files, an interface called Jmail that mimics a Gmail inbox, is hosted on Guillermo Rauch’s $9 billion unicorn Vercel.
An Israeli startup let its AI loose in advanced cyber games. It did better than 125,000 humans.
Roche’s rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.
his week’s Current Climate newsletter also looks at Tesla’s best business bet and accelerating the shift from fossil fuels for stability and energy security
Last week, we tracked more than 85 tech funding deals worth over €4 billion, and over 5 exits, M&A transactions, rumours, and related news stories across Europe.Haberin devamını okumak için tıklayınız…
How a new startup plans to power satellites with lasers. A new class of ultrafast AI chips also uses lasers. And startup Axiomatic AI is building better AI models for science and engineering.